- Home
- AGRO vs IVA Comparison
AGRO vs IVA Comparison
Compare AGRO & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGRO
- IVA
- Stock Information
- Founded
- AGRO 2002
- IVA 2011
- Country
- AGRO Luxembourg
- IVA France
- Employees
- AGRO N/A
- IVA N/A
- Industry
- AGRO Farming/Seeds/Milling
- IVA Biotechnology: Pharmaceutical Preparations
- Sector
- AGRO Consumer Staples
- IVA Health Care
- Exchange
- AGRO Nasdaq
- IVA Nasdaq
- Market Cap
- AGRO 790.5M
- IVA 769.0M
- IPO Year
- AGRO 2011
- IVA 2020
- Fundamental
- Price
- AGRO $7.69
- IVA $3.97
- Analyst Decision
- AGRO Sell
- IVA Strong Buy
- Analyst Count
- AGRO 2
- IVA 8
- Target Price
- AGRO $9.00
- IVA $16.13
- AVG Volume (30 Days)
- AGRO 436.0K
- IVA 482.1K
- Earning Date
- AGRO 11-11-2025
- IVA 09-29-2025
- Dividend Yield
- AGRO 4.56%
- IVA N/A
- EPS Growth
- AGRO N/A
- IVA N/A
- EPS
- AGRO 0.23
- IVA N/A
- Revenue
- AGRO $1,386,018,000.00
- IVA $19,929,536.00
- Revenue This Year
- AGRO N/A
- IVA N/A
- Revenue Next Year
- AGRO $0.66
- IVA N/A
- P/E Ratio
- AGRO $32.96
- IVA N/A
- Revenue Growth
- AGRO N/A
- IVA N/A
- 52 Week Low
- AGRO $7.42
- IVA $2.11
- 52 Week High
- AGRO $11.79
- IVA $7.98
- Technical
- Relative Strength Index (RSI)
- AGRO 44.22
- IVA 41.35
- Support Level
- AGRO $7.63
- IVA $3.55
- Resistance Level
- AGRO $8.26
- IVA $4.10
- Average True Range (ATR)
- AGRO 0.28
- IVA 0.57
- MACD
- AGRO -0.02
- IVA -0.05
- Stochastic Oscillator
- AGRO 16.48
- IVA 9.02
About AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.